Biggest News Aggregation in the World
📰 Immunic News

Page 10 - Immunic News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Immunic. Real-time updates on events, politics, business and more.

DGAP-News: Immunic to Participate in Industry and Scientific Conferences in July

Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Industry and Scientific Conferences in July 28.06.2022 / 12:30 The issuer is solely responsible for the content of this announcement. Immunic to Participate in Industry and Scientific Conferences in July NEW YORK, June 28,...
United States Switzerland General Edna Kaplan Paula Schwartz Jessica Breu Evelyn Peelen

DGAP-News: Immunic, Inc.: Immunic Announces Publication of Data From Its Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis in Peer Reviewed Journal, Annals of Clinical and Translational N

Issuer: Immunic, Inc. / Key word(s): Scientific publication/Study results Immunic Announces Publication of Data From Its Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting
United States Edna Kaplan Paula Schwartz Jessica Breu Robertj Fox Daniel Vitt

Immunic Announces Publication of Data From Its Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis in Peer Reviewed Journal, Annals of Clinical and Translational Neurology

NEW YORK, June 15, 2022 /PRNewswire/ -- Immunic, Inc. , a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic... | June 15, 2022
United States Edna Kaplan Paula Schwartz Jessica Breu Robertj Fox Daniel Vitt

DGAP-News: Immunic, Inc. to Participate in Scientific, Industry and Investor Conferences in June

Issuer: Immunic, Inc. / Key word(s): Conference Immunic, Inc. to Participate in Scientific, Industry and Investor Conferences in June 08.06.2022 / 12:30 The issuer is solely responsible for the content of this announcement. Immunic, Inc. to Participate in Scientific, Industry and Investor Confer...
New York United States San Diego Edna Kaplan Paula Schwartz Jessica Breu

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Immunic, Inc. (NASDAQ:IMUX) CFO Buys $10,640.00 in Stock

Immunic, Inc. (NASDAQ:IMUX – Get Rating) CFO Glenn Whaley bought 3,500 shares of the company’s stock in a transaction dated Friday, June 3rd. The stock was acquired at an average price of $3.04 per share, for a total transaction of $10,640.00. Following the acquisition, the chief financial officer now directly owns 12,568 shares in the […]
Glenn Whaley Piper Sandler Immunic Company Profile Get Rating Securities Exchange Commission Zacks Investment Research Sphera Funds Management

Immunic, Inc. (NASDAQ:IMUX) CEO Daniel Vitt Acquires 5,000 Shares

Immunic, Inc. (NASDAQ:IMUX – Get Rating) CEO Daniel Vitt purchased 5,000 shares of Immunic stock in a transaction on Friday, June 3rd. The stock was bought at an average price of $3.10 per share, for a total transaction of $15,500.00. Following the completion of the acquisition, the chief executive officer now owns 368,877 shares in […]
Zurcher Kantonalbank Zurich Cantonalbank Piper Sandler Daniel Vitt Immunic Company Profile Get Rating Wells Fargo Company Zacks Investment Research

Immunic, Inc. (NASDAQ:IMUX) Given Average Rating of "Hold" by Analysts

Shares of Immunic, Inc. (NASDAQ:IMUX – Get Rating) have been assigned a consensus rating of “Hold” from the six analysts that are covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation and three have given a buy recommendation to the company. The average 1-year price objective among brokerages that […]
Duane Nash Piper Sandler Northern Trust Corp Goldman Sachs Group Inc Zacks Investment Research Silverarc Capital Management

DGAP-News: Immunic, Inc. Reports Top-Line Data from Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium in Patients with Moderate-to-Severe Ulcerative Colitis and Provides Corporate Update

Issuer: Immunic, Inc. / Key word(s): Study results Immunic, Inc. Reports Top-Line Data from Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium in Patients with Moderate-to-Severe Ulcerative Colitis
United States Paula Schwartz Edna Kaplan Jessica Breu Andreas Muehler Daniel Vitt

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science